This study investigates the molecular mechanisms of colistin and carbapenem resistance in Klebsiella pneumoniae ST101 strains. The three K. pneumoniae carried blaCTX-M-15, blaTEM-183, and blaSHV-106 genes and two coharbored blaOXA-48. As for colistin resistance, the isolates had amino acid substitutions in PmrA/B and a truncated mgrB gene in one isolate.
Get full access to this article
View all access options for this article.
References
1.
BiswasS., BrunelJ.M., DubusJ.C., Reynaud-GaubertM., RolainJ.M.. 2012. Colistin: an update on the antibiotic of the 21st century. Expert. Rev. Anti. Infect. Ther. 10:917–934.
2.
OlaitanA.O., MorandS., and RolainJ.M.. 2014. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front. Microbiol. 5:1–18.
3.
PotronA., PoirelL., RondinaudE., and NordmannP.. 2013. Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Eurosurveillance, 18:20549.
4.
NovovićK., TrudićA., BrkićS., VasiljevićZ., KojićM., MedićD., I. Ćirković, and JovčićB.. 2017. Molecular epidemiology of colistin-resistant, carbapenemase-producing Klebsiella pneumoniae, Serbia, 2013–2016. Antimicrob. Agents Chemother. 24:e02550-16.
5.
BakourS., OlaitanA.O., AmmariH., TouatiA., SaoudiS., SaoudiK., and RolainJ.M.. 2015. Emergence of colistin- and carbapenem-resistant Acinetobacter baumannii ST2 clinical isolate in Algeria: first case report. Microb. Drug Resist. 21:279–285.
6.
YanatB., MachucaJ., YahiaR.D., TouatiA., and Á. Pascual. 2016. First report of the plasmid-mediated colistin resistance gene mcr-1 in a clinical Escherichia coli isolate in Algeria. Int. J. Antimicrob. Agents, 48:760–761.
7.
OlaitanA.O., ChabouS., OkdahL., MorandS., and RolainJ.M.. 2016. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect. Dis. 16:147.
8.
ChengY.H., LinT.L., LinY.T., and WangJ.T.. 2016. Amino acid substitutions of CrrB responsible for resistance to colistin through CrrC in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 60:3709–3716.
9.
OlaitanA.O., DieneS.M., KempfM., BerrazegM., BakourS., GuptaS.K., ThongmalayvongB., AkkhavongK., SomphavongS., PaboribouneP., ChaisiriK., KomalamisraC., AdelowoO.O., FagadeO.E., BanjoO.A., OkeA.J., AdlerA., AssousM.V., MorandS., RaoultD., and RolainJ.M.. 2014. Emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study. Int. J. Antimicrob. Agents, 44:500–507.
10.
EdelsteinM., PimkinM., PalaginI., EdelsteinI., and StratchounskiL.. 2013. Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob. Agents Chemother. 47:3724–3732.
11.
RoschanskiN., FischerJ., GuerraB., and RoeslerU.. 2014. Development of a multiplex real-time PCR for the rapid detection of the predominant beta-lactamase genes CTX-M, SHV, TEM and CIT-type AmpCs in Enterobacteriaceae. PLoS One, 9:e100956.
12.
YagiT., KurokawaH., ShibataN., ShibayamaK., and ArakawaY.. 2000. A preliminary survey of extended-spectrum B-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol. Lett, 184:53–56.
13.
KrugerT., SzaboD., KeddyK.H., DeeleyK., MarshJ.W., HujerA.M., BonomoR.A., and PatersonD.L.. 2004. Infections with nontyphoidal Salmonella species producing TEM-63 or a novel TEM enzyme, TEM-131, in South Africa. Antimicrob. Agents Chemother. 48:4263–4270.
14.
PoirelL., NaasT., and NordmannP.. 2010. Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob. Agents Chemother. 54:24–38.
15.
DieneS.M., BruderN., RaoultD., and RolainJ.M.. 2011. Real-time PCR assay allows detection of the New Delhi metallo-β- lactamase (NDM-1)-encoding gene in France. Int. J. Antimicrob. Agents, 37:544–546.
16.
SengP., DrancourtM., GourietF., La ScolaB., FournierP.E., RolainJ.M., and RaoultD.. 2009. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin. Infect. Dis. 49:543–551.
17.
BaronS., HadjadjL., RolainJ.M., and OlaitanA.O.. 2016. Molecular mechanisms of polymyxin resistance: knowns and unknowns. Int. J. Antimicrob. Agents, 48:583–591.
18.
OlaitanA.O., and RolainJ.M.. 2015. Interruption of mgrB in the mediation of colistin resistance in Klebsiella oxytoca. Int. J. Antimicrob. Agents, 46:354–356.
19.
PoirelL., JayolA., and NordmannP.. 2017. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin. Microbiol. Rev. 30:557–596.
20.
AiresC.A.M., PereiraP.S., AsensiM.D., and A.P.D. Carvalho-Assef. 2016. MgrB mutations mediating polymyxin B resistance in Klebsiella pneumoniae isolates from rectal surveillance swabs in Brazil. Antimicrob. Agents Chemother. 60:6969–6972.
21.
JayolA., PoirelL., BrinkA., VillegasM.V., YilmazM., and NordmannP.. 2014. Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin. Antimicrob. Agents Chemother. 58:4762–4766.
22.
HrabakJ., EmpelJ., BergerovaT., FajfrlikK., UrbaskovaP., Kern-ZdanowiczI., HryniewiczW., and GniadkowskiM.. 2009. International clones of Klebsiella pneumoniae and Escherichia coli with extended-spectrum β-lactamases in a Czech Hospital. J. Clin. Microbiol. 47:3353–3357.
23.
KaaseM., SchimanskiS., SchillerR., BeyreißB., ThürmerA., SteinmannJ., KempfV.A., HessC., SobottkaI., FennerI., ZiesingS., BurckhardtI., von MüllerL., HamprechtA., TammerI., WantiaN., BeckerK., HolzmannT., FuritschM., VolmerG., and GatermannS.G.. 2016. Multicentre investigation of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in German Hospitals. Int. J. Med. Microbiol. 306:415–420.
24.
De LaveleyeM., HuangT.D., BogaertsP., BerhinC., BauraingC., SacréP., NoelA., and GlupczynskiY.. 2017. Increasing incidence of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Belgian Hospitals. Eur. J. Clin. Microbiol. Infect. Dis. 36:139–146.
25.
SekiL.M., PereiraP.S., de Souza M daM.da.P., ConceiçãoM.de.S., MarquesE.A., PortoC.O., ColnagoE.M.L., AlvesC.de.F.M., GomesD., AssefA.P.D.A.C., and SamuelsenO., AsensiM.D.. 2011. Molecular epidemiology of KPC-2-producing Klebsiella pneumoniae isolates in Brazil: the predominance of sequence type 437. Diagn. Microbiol. Infect. Dis., 70:274–277.
26.
MarkovskaR., StoevaT., SchneiderI., BoyanovaL., PopovaV., DachevaD., KanevaR., BauernfeindA., MitevV., and MitovI.. 2015. Clonal dissemination of multilocus sequence type ST15 KPC-2-producing Klebsiella pneumoniae in Bulgaria. APMIS, 123:887–894.
27.
YuJ., WangY., ChenZ., ZhuX., TianL., LiL., and SunZ.. 2017. Outbreak of nosocomial NDM-1-producing Klebsiella pneumoniae ST1419 in a neonatal unit. J. Glob. Antimicrob. Resist. 8:135–139.
28.
OteoJ., SaezD., BautistaV., Fernandez-RomeroS., Hernandez-MolinaJ.M., Perez-VazquezM., AracilB., and CamposJ.. 2013. Carbapenemase-producing Enterobacteriaceae in Spain in 2012. Antimicrob. Agents Chemother. 57:6344–6347.
29.
KirveskariJ., HakanenA.J., and MonicaO.. 2012. Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008–2011). J. Antimicrob. Chemother. 67:2860–2864.
30.
Liapis E., PantelA., RobertJ., Nicolas-ChanoineM.H., CavaliéL., Van der Mee-MarquetN., De ChampsC., AissaN., EloyC., BlancV., GuyeuxC., HocquetD., LavigneJ.P., and BertrandX.. 2014. Molecular epidemiology of OXA-48-producing Klebsiella pneumoniae in. France. Clin. Microbiol. Infect., 20:1121–1123.
31.
MshanaS.E., FritzenwankerM., FalgenhauerL., DomannE., and HainT.. 2015. Molecular epidemiology and characterization of an outbreak causing Klebsiella pneumoniae clone carrying chromosomally located bla CTX-M-15 at a German University-Hospital. BMC Microbiol. 15:122.
32.
MeleghS., SchneiderG., HorváthM., JakabF., EmődyL., and TigyiZ.. 2015. Identification and characterization of CTX-M-15 producing Klebsiella pneumoniae clone ST101 in a Hungarian university teaching hospital. Acta. Microbiol. Immunol. Hung. 62:233–245.
33.
MamminaC., BonuraC., AleoA., FascianaT., BrunelliT., PesaventoG., Degl'Innocenti RR., and NastasiA.. 2012. Sequence type 101 (ST101) as the predominant carbapenem-non-susceptible Klebsiella pneumoniae clone in an acute general hospital in Italy. Int. J. Antimicrob. Agents, 39:543–545.
34.
FrassonI., LavezzoE., FranchinE., ToppoS., BarzonL., CavallaroA., RichterS.N., and PaluG.. 2012. Antimicrobial treatment and containment measures for an extremely drug-resistant Klebsiella pneumoniae ST101 isolate carrying pKPN101-IT, a novel fully sequenced blaKPC-2 plasmid. J. Clin. Microbiol. 50:3768–3772.
35.
HashimotoA., NagamatsuM., OhmagariN., HayakawaK., KatoY., and KirikaeT.. 2014. Isolation of OXA-48 carbapenemase-producing Klebsiella pneumonia ST101 from an overseas traveler returning to Japan. Jpn. J. Infect. Dis. 67:120–121.
36.
LeeS.-Y., ParkY.-J., YuJ.K., JungS., KimY., JeongS.H., and ArakawaY.. 2012. Prevalence of acquired fosfomycin resistance among extended-spectrum-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3. J. Antimicrob. Chemother. 67:2843–2847.
37.
PenaI., PicazoJ.J., Rodríguez-avialC., and Rodríguez-avialI.. 2014. Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates. Int. J. Antimicrob. Agents, 43:460–464.
38.
MarcadeG., BrisseS., BialekS., MarconE., Leflon-GuiboutV., PassetV., MoreauR., and Nicolas-ChanoineM.-H.. 2013. The emergence of multidrug-resistant Klebsiella pneumoniae of international clones ST13, ST16, ST35, ST48 and ST101 in a teaching hospital in the Paris region. Epidemiol. Infect. 141:1705–1712.
39.
SkálováA., ChudějováK., RotováV., MedveckyM., V. Študentová, ChudáčkováE., LavickaP., BergerovaT., JakubuV., ZemlickovaH., PapagiannitsisC.C., and HrabákJ.. 2016. Molecular characterization of OXA-48-like-producing Enterobacteriaceae in the Czech Republic: evidence for horizontal transfer of pOXA-48-like plasmids. Antimicrob. Agents Chemother. 188:9–16.
40.
VendittiC., VillaL., CaponeA., FortiniD., D'ArezzoS., NisiiC., BordiE., PuroV., AntoniniM., CarattoliA., CataldoM.A., PetrosilloN., and Di CaroA.. 2016. Isolation of KPC 3-producing Enterobacter aerogenes in a patient colonized by MDR Klebsiella pneumoniae. New Microbiol. 39:310–313.
41.
PitartC., SoleM., RocaI., FabregaA., VilaJ., and MarcoF.. 2011. First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48-lactamase in Klebsiella pneumoniae in Spain. Antimicrob. Agents Chemother., 55:4398–4401.
42.
IzdebskiR., BojarskaK., BaraniakA., LiterackaE., HerdaM., ŻabickaD., GuzekA., PółgrabiaM., HryniewiczW., and GniadkowskiM.. 2015. NDM-1 or OXA-48-producing Enterobacteriaceae colonising Polish tourists following a terrorist attack in Tunis. Eurosurveillance, 20:1–4.
43.
MaamarE., FerjaniS., JendoubiA., HammamiS., HamzaouiZ., Mayonnove-CoulangeL., SaidaniM., KammounA., RehaiemA., GhediraS., HouissaM., Boutiba-Ben BoubakerI., SlimA., and DuboisV.. 2016. High prevalence of gut microbiota colonization with broad-spectrum cephalosporin resistant Enterobacteriaceae in a Tunisian intensive care unit. Front. Microbiol. 7:1–10.
44.
MansourW., HaenniM., SarasE., GramiR., ManiY., Ben Haj KhalifaA., El AtroussS., KhederM., Fekih HassenM., BoujâafarN., BouallegueO., and MadecJ.Y.. 2017. Outbreak of colistin-resistant carbapenemase-producing Klebsiella pneumoniae in Tunisia. J. Glob. Antimicrob. Resist. 10:88–94.
45.
OkdahL., LeangapichartT., HadjadjL., OlaitanA.O., Al-BayssariC., RizkR., HammoudM., DieneS.M., and RolainJ.M.. 2017. First report of colistin-resistant Klebsiella pneumoniae clinical isolates in Lebanon. J. Glob. Antimicrob. Resist. 9:15–16.
